RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ana M. Espino to Humans

This is a "connection" page, showing publications Ana M. Espino has written about Humans.
Connection Strength

0.583
  1. Espino AM, Armina-Rodriguez A, Alvarez L, Ocasio-Malav? C, Ramos-Nieves R, Rodriguez Martin? EI, L?pez-Marte P, Torres EA, Sariol CA. The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine. Viruses. 2024 01 26; 16(2).
    View in: PubMed
    Score: 0.044
  2. Espino A, Gouilly J, Chen Q, Colin P, Guerby P, Izopet J, Amara A, Tabiasco J, Al-Daccak R, El Costa H, Jabrane-Ferrat N. The mechanisms underlying the immune control of Zika virus infection at the maternal-fetal interface. Front Immunol. 2022; 13:1000861.
    View in: PubMed
    Score: 0.041
  3. Sariol CA, Serrano-Collazo C, Ortiz EJ, Pantoja P, Cruz L, Arana T, Atehortua D, Pabon-Carrero C, Espino AM. Limited Impact of Delta Variant's Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population. Viruses. 2021 11 30; 13(12).
    View in: PubMed
    Score: 0.038
  4. Sariol CAA, Pantoja P, Serrano-Collazo C, Rosa-Arocho T, Armina-Rodr?guez A, Cruz L, Stone ETT, Arana T, Climent C, Latoni G, Atehortua D, Pabon-Carrero C, Pinto AKK, Brien JDD, Espino AMM. Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination. Viruses. 2021 09 30; 13(10).
    View in: PubMed
    Score: 0.038
  5. Figueroa-Santiago O, Espino A. Purification of Native Fasciola hepatica Fatty Acid-Binding Protein and Induction of Alternative Activation of Human Macrophages. Methods Mol Biol. 2020; 2137:149-169.
    View in: PubMed
    Score: 0.033
  6. Figueroa-Santiago O, Espino A. Possible Role for Toll-Like Receptors in Interaction of Fasciola hepatica Excretory-Secretory Products with Human Monocyte Cell Line. Methods Mol Biol. 2020; 2137:171-180.
    View in: PubMed
    Score: 0.033
  7. Aguayo V, Vald?s Fernandez BN, Rodr?guez-Valent?n M, Ruiz-Jim?nez C, Ramos-Ben?tez MJ, M?ndez LB, Espino AM. Fasciola hepatica GST downregulates NF-?B pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model. Sci Rep. 2019 02 19; 9(1):2275.
    View in: PubMed
    Score: 0.031
  8. Ramos-Ben?tez MJ, Lopez-Cruz LM, Aguayo V, Ruiz-Jimenez C, Espino AM. Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2. Mol Biol Rep. 2018 Oct; 45(5):1551-1556.
    View in: PubMed
    Score: 0.030
  9. Aguayo V, Valdes B, Espino AM. Assessment of Fasciola hepatica glutathione S-transferase as an antigen for serodiagnosis of human chronic fascioliasis. Acta Trop. 2018 Oct; 186:41-49.
    View in: PubMed
    Score: 0.030
  10. Ramos-Ben?tez MJ, Ruiz-Jim?nez C, Aguayo V, Espino AM. Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands. Sci Rep. 2017 07 14; 7(1):5455.
    View in: PubMed
    Score: 0.028
  11. Figueroa-Santiago O, Espino AM. Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages. Infect Immun. 2014 Dec; 82(12):5005-12.
    View in: PubMed
    Score: 0.023
  12. Cab?n-Hern?ndez K, Gaudier JF, Ruiz-Jim?nez C, Espino AM. Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis. J Clin Microbiol. 2014 Mar; 52(3):766-72.
    View in: PubMed
    Score: 0.022
  13. Cab?n-Hern?ndez K, Espino AM. Differential expression and localization of saposin-like protein 2 of Fasciola hepatica. Acta Trop. 2013 Dec; 128(3):591-7.
    View in: PubMed
    Score: 0.022
  14. Morales A, Espino AM. Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis. Clin Vaccine Immunol. 2012 Nov; 19(11):1870-8.
    View in: PubMed
    Score: 0.020
  15. Gaudier JF, Cab?n-Hern?ndez K, Osuna A, Espino AM. Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica. Clin Vaccine Immunol. 2012 Mar; 19(3):325-33.
    View in: PubMed
    Score: 0.019
  16. Figueroa-Santiago O, Delgado B, Espino AM. Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagn Microbiol Infect Dis. 2011 Jul; 70(3):355-61.
    View in: PubMed
    Score: 0.019
  17. Miralles F, Tarong? S, Espino A. Quantitative evaluation of the drawing of a spiral on a paper. Mov Disord. 2011 Jun; 26(7):1369; author reply 1369-70.
    View in: PubMed
    Score: 0.018
  18. Boukli NM, Delgado B, Ricaurte M, Espino AM. Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis. J Parasitol. 2011 Oct; 97(5):852-61.
    View in: PubMed
    Score: 0.018
  19. Pujol A, Sanchis P, Tamayo MI, Nicolau J, Grases F, Espino A, Estremera A, Rigo E, Amengual GJ, Rodr?guez M, Ribes JL, Gomila I, Sim?-Servat O, Masmiquel L. Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial). Front Endocrinol (Lausanne). 2024; 15:1332237.
    View in: PubMed
    Score: 0.011
  20. Tosado-Rodr?guez E, Mendez LB, Espino AM, Dorta-Estremera S, Aquino EE, Romaguera J, Godoy-Vitorino F. Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico. PLoS One. 2023; 18(12):e0284673.
    View in: PubMed
    Score: 0.011
  21. Espino AM, Hillyer GV. Molecular cloning of a member of the Fasciola hepatica saposin-like protein family. J Parasitol. 2003 Jun; 89(3):545-52.
    View in: PubMed
    Score: 0.011
  22. Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K. The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization. mSphere. 2022 08 31; 7(4):e0019322.
    View in: PubMed
    Score: 0.010
  23. Vald?s-Fern?ndez BN, Duconge J, Espino AM, Rua?o G. Personalized health and the coronavirus vaccines-Do?individual genetics matter? Bioessays. 2021 09; 43(9):e2100087.
    View in: PubMed
    Score: 0.009
  24. Chen Q, Gouilly J, Ferrat YJ, Espino A, Glaziou Q, Cartron G, El Costa H, Al-Daccak R, Jabrane-Ferrat N. Metabolic reprogramming by Zika virus provokes inflammation in human placenta. Nat Commun. 2020 06 11; 11(1):2967.
    View in: PubMed
    Score: 0.009
  25. Shin SH, Hsu A, Chastain HM, Cruz LA, Elder ES, Sapp SG, McAuliffe I, Espino AM, Handali S. Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis. Am J Trop Med Hyg. 2016 Oct 05; 95(4):852-855.
    View in: PubMed
    Score: 0.007
  26. De Pablos LM, D?az Lozano IM, Jercic MI, Quinzada M, Gim?nez MJ, Calabuig E, Espino AM, Schijman AG, Zulantay I, Apt W, Osuna A. The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles. Sci Rep. 2016 06 08; 6:27293.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support